Literature DB >> 27467952

Priming of neutrophils toward NETosis promotes tumor growth.

Mélanie Demers1, Siu Ling Wong1, Kimberly Martinod1, Maureen Gallant2, Jessica E Cabral2, Yanming Wang3, Denisa D Wagner4.   

Abstract

Neutrophils play a major role in cancer biology and both pro- and antitumoral functions of tumor-infiltrating neutrophils have been described. We have shown that tumors, by releasing G-CSF into the bloodstream, prime circulating neutrophils to form neutrophil extracellular traps (NETs) and we have detected the presence of NETs within the tumor microenvironment. Here, we report, using PAD4-deficient mice with a defect in neutrophil chromatin decondensation and NET formation, that the priming of neutrophils toward NETosis favors tumor growth. Interestingly, in a tumor model that does not release G-CSF and in which neutrophils are not primed for NETosis, PAD4-deficiency did not reduce tumor growth. However, supplying exogenous G-CSF to the wild-type (WT) host promoted intratumoral NETosis and tumor growth. Taken together, our results suggest that the priming of neutrophils for NETosis by the tumor or its environment leads to the accumulation of intratumoral NETs and a growth advantage to the tumor. Our work unveiled a pro-tumoral role for NETs which strengthens their potential as a new target in the fight against cancer.

Entities:  

Keywords:  Cancer; G-CSF; NETs; neutrophils; tumor growth

Year:  2016        PMID: 27467952      PMCID: PMC4910712          DOI: 10.1080/2162402X.2015.1134073

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  38 in total

1.  Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.

Authors:  A el-Hag; R A Clark
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

2.  Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity.

Authors:  Kathleen D Metzler; Tobias A Fuchs; William M Nauseef; Dominique Reumaux; Joachim Roesler; Ilka Schulze; Volker Wahn; Venizelos Papayannopoulos; Arturo Zychlinsky
Journal:  Blood       Date:  2010-10-25       Impact factor: 22.113

3.  Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.

Authors:  Xiaotian Chang; Jinxiang Han
Journal:  Mol Carcinog       Date:  2006-03       Impact factor: 4.784

4.  Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression.

Authors:  Inbal Mishalian; Rachel Bayuh; Liran Levy; Lida Zolotarov; Janna Michaeli; Zvi Gregorio Fridlender
Journal:  Cancer Immunol Immunother       Date:  2013-10-04       Impact factor: 6.968

Review 5.  Thrombosis: tangled up in NETs.

Authors:  Kimberly Martinod; Denisa D Wagner
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113

6.  Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.

Authors:  Jaime Morales-Arias; Paul A Meyers; Marcela F Bolontrade; Nidra Rodriguez; Zhichao Zhou; Krishna Reddy; Alexander J Chou; Nadezhda V Koshkina; Eugenie S Kleinerman
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

7.  Novel cell death program leads to neutrophil extracellular traps.

Authors:  Tobias A Fuchs; Ulrike Abed; Christian Goosmann; Robert Hurwitz; Ilka Schulze; Volker Wahn; Yvette Weinrauch; Volker Brinkmann; Arturo Zychlinsky
Journal:  J Cell Biol       Date:  2007-01-08       Impact factor: 10.539

8.  Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.

Authors:  Huw D Lewis; John Liddle; Jim E Coote; Stephen J Atkinson; Michael D Barker; Benjamin D Bax; Kevin L Bicker; Ryan P Bingham; Matthew Campbell; Yu Hua Chen; Chun-Wa Chung; Peter D Craggs; Rob P Davis; Dirk Eberhard; Gerard Joberty; Kenneth E Lind; Kelly Locke; Claire Maller; Kimberly Martinod; Chris Patten; Oxana Polyakova; Cecil E Rise; Martin Rüdiger; Robert J Sheppard; Daniel J Slade; Pamela Thomas; Jim Thorpe; Gang Yao; Gerard Drewes; Denisa D Wagner; Paul R Thompson; Rab K Prinjha; David M Wilson
Journal:  Nat Chem Biol       Date:  2015-01-26       Impact factor: 15.040

9.  The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.

Authors:  B A Boone; L Orlichenko; N E Schapiro; P Loughran; G C Gianfrate; J T Ellis; A D Singhi; R Kang; D Tang; M T Lotze; H J Zeh
Journal:  Cancer Gene Ther       Date:  2015-04-24       Impact factor: 5.987

10.  A proposed role for neutrophil extracellular traps in cancer immunoediting.

Authors:  Sivan Berger-Achituv; Volker Brinkmann; Ulrike Abu Abed; Lars I Kühn; Jonathan Ben-Ezra; Ronit Elhasid; Arturo Zychlinsky
Journal:  Front Immunol       Date:  2013-03-06       Impact factor: 7.561

View more
  88 in total

1.  Kindlin-3 negatively regulates the release of neutrophil extracellular traps.

Authors:  Zhen Xu; Beiwen Ni; Zhongyuan Cao; Jacek Zielonka; Juan Gao; Fangyuan Chen; Balaraman Kalyanaraman; Gilbert C White; Yan-Qing Ma
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

Review 2.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

Review 3.  Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging.

Authors:  Arya Biragyn; Luigi Ferrucci
Journal:  Lancet Oncol       Date:  2018-06-01       Impact factor: 41.316

Review 4.  Neutrophil extracellular traps in immunity and disease.

Authors:  Venizelos Papayannopoulos
Journal:  Nat Rev Immunol       Date:  2017-10-09       Impact factor: 53.106

5.  Peptidylarginine deiminase 4: a nuclear button triggering neutrophil extracellular traps in inflammatory diseases and aging.

Authors:  Siu Ling Wong; Denisa D Wagner
Journal:  FASEB J       Date:  2018-06-20       Impact factor: 5.191

Review 6.  The Tumor Microenvironment Innately Modulates Cancer Progression.

Authors:  Dominique C Hinshaw; Lalita A Shevde
Journal:  Cancer Res       Date:  2019-07-26       Impact factor: 12.701

7.  Primary tumors induce neutrophil extracellular traps with targetable metastasis promoting effects.

Authors:  Roni F Rayes; Jack G Mouhanna; Ioana Nicolau; France Bourdeau; Betty Giannias; Simon Rousseau; Daniela Quail; Logan Walsh; Veena Sangwan; Nicholas Bertos; Jonathan Cools-Lartigue; Lorenzo E Ferri; Jonathan D Spicer
Journal:  JCI Insight       Date:  2019-07-25

Review 8.  Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

9.  Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.

Authors:  Irina Lerman; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Luis Chiriboga; Chunliu Pan; Kent L Nastiuk; John J Krolewski; Aritro Sen; Stephen R Hammes
Journal:  Mol Cancer Res       Date:  2017-05-16       Impact factor: 5.852

10.  Peptidylarginine Deiminase IV Regulates Breast Cancer Stem Cells via a Novel Tumor Cell-Autonomous Suppressor Role.

Authors:  Nellie Moshkovich; Humberto J Ochoa; Binwu Tang; Howard H Yang; Yuan Yang; Jing Huang; Maxwell P Lee; Lalage M Wakefield
Journal:  Cancer Res       Date:  2020-04-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.